• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • WORLD EDITION
      Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • WORLD EDITION
      North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Minerals
    Tech
    Life Science
    Medical Device Market
    Medical Device News
    Medical Device Stocks
    • Medical Device Market
    • Medical Device News
    • Medical Device Stocks
    medical device investing

    Allscripts announces fourth quarter and 2017 full-year results

    Written by Gabrielle Lakusta
    |
    Feb. 16, 2018 08:44AM PST

    Allscripts Healthcare Solutions (NASDAQ:MDRX) announced its financial results for the three months and year ended December 31, 2017. As quoted in the press release: Fourth quarter 2017 GAAP revenue was $517 million, an increase of 22 percent year-over-year. Non-GAAP revenue totaled $547 million, improving 27 percent year-over-year. For the year ended December 31, 2017, GAAP …

    Allscripts Healthcare Solutions (NASDAQ:MDRX) announced its financial results for the three months and year ended December 31, 2017.

    As quoted in the press release:

    Fourth quarter 2017 GAAP revenue was $517 million, an increase of 22 percent year-over-year. Non-GAAP revenue totaled $547 million, improving 27 percent year-over-year. For the year ended December 31, 2017, GAAP revenue totaled $1,806 million, an increase of 17 percent year-over-year. Non-GAAP revenue totaled $1,841 million, also a 17 percent increase from 2016.

    Click here to read the full press release.

    medical device investingfinancial results
    The Conversation (0)

    Go Deeper

    AI Powered

    The Ensign Group Reports Fourth Quarter and Fiscal Year 2017 Results

    Ebix Reports Q2 2017 Results

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
      • Electric Vehicles
    • Agriculture
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Energy
      • Uranium
      • Oil and Gas
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Robotics
      • Crypto
      • Cleantech
    Life Science
      • Biotech
      • Cannabis
      • Pharmaceuticals

    Featured Medical Device Investing Stocks

    Cleo Diagnostics

    Cleo Diagnostics (COV:AU)
    COV:AU

    Avricore Health

    Avricore Health (AVCR:CC)
    AVCR:CC
    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES